Index
RUT
Market Cap
3.50B
Enterprise Value
4.49B
Income
4.00M
Sales
1.86B
Book/sh
40.84
Cash/sh
10.48
Employees
2900
IPO
May 08, 1950
P/E
878.16
Forward P/E
15.56
PEG
0.92
P/S
1.88
P/B
1.87
P/C
7.29
P/FCF
11.86
EV/EBITDA
12.72
EV/Sales
2.41
Quick Ratio
1.89
Current Ratio
2.96
Debt/Eq
0.80
LT Debt/Eq
0.78
Option/Short
Yes / Yes
EPS (ttm)
0.09
EPS next Y
4.91
EPS next Q
0.38
EPS this Y
27.65%
EPS next Y
16.17%
EPS next 5Y
16.91%
EPS past 3/5Y
-70.41% -52.65%
Sales past 3/5Y
-5.26% -2.47%
EPS Y/Y TTM
106.07%
Sales Y/Y TTM
2.08%
EPS Q/Q
-150.00%
Sales Q/Q
4.18%
Insider Own
1.29%
Insider Trans
0.00%
Inst Own
115.93%
Inst Trans
-3.70%
ROA
0.55%
ROE
1.33%
ROIC
0.12%
Gross Margin
27.48%
Oper. Margin
7.25%
Profit Margin
0.21%
SMA20
1.93%
SMA50
6.04%
SMA200
18.24%
Trades
Shs Outstand
45.79M
Shs Float
45.20M
52W High
79.50 -3.90%
52W Low
48.00 59.17%
Volatility
3.11% 2.84%
ATR (14)
2.12
RSI (14)
58.01
Beta
0.36
Rel Volume
1.28
Avg Volume
641.23K
Volume
823,906
Perf Week
-0.42%
Perf Month
6.57%
Perf Quarter
4.92%
Perf Half Y
36.45%
Perf YTD
30.22%
Perf Year
52.74%
Perf 3Y
-0.65%
Perf 5Y
-28.15%
Perf 10Y
40.53%
Prev Close
74.15
Price
76.40
Change %
3.03%
Analysts 12 incl. previous ratings
Rating Distribution 8 Buy · 4 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside May 06, 2026 Upgrade S Seaport Research Partners
Neutral → Buy $75 -1.8% Dec 15, 2025 Upgrade B BMO Capital Markets
Market Perform → Outperform $71 -7.1% Sep 08, 2025 Initiated M Morgan Stanley
Equal-Weight $60 -21.5% May 01, 2025 Downgrade W Wells Fargo
Overweight → Equal Weight Mar 26, 2025 Upgrade J JP Morgan
Neutral → Overweight $68 → $71 -7.1% Mar 05, 2025 Downgrade S Seaport Research Partners
Buy → Neutral Aug 08, 2024 Upgrade J JP Morgan
Underweight → Neutral $90 → $89 +16.5% Apr 11, 2024 Upgrade W Wells Fargo
Equal Weight → Overweight $100 → $112 +46.6% Mar 14, 2024 Upgrade J Jefferies
Hold → Buy $100 → $126 +64.9% Mar 01, 2024 Initiated W Wolfe Research
Outperform $108 +41.4% Jun 29, 2023 Downgrade E Evercore ISI
Outperform → In-line Jun 26, 2023 Downgrade B BMO Capital Markets
Outperform → Market Perform $109 → $90 +17.8% Feb 02, 2023 Downgrade J JP Morgan
Neutral → Underweight $104 → $105 +37.4% Sep 12, 2022 Initiated C Credit Suisse
Outperform $120 +57.1% Jan 20, 2022 Downgrade W Wells Fargo
Overweight → Equal Weight $120 → $110 +44.0% Nov 11, 2021 Downgrade M Monness Crespi & Hardt
Buy → Neutral Oct 13, 2021 Initiated M Mizuho
Buy $116 +51.8% Jul 30, 2021 Upgrade J JP Morgan
Underweight → Neutral $90 +17.8% Jun 18, 2021 Initiated S Stifel
Buy $118 +54.5% May 04, 2021 Downgrade J JP Morgan
Neutral → Underweight $88 → $89 +16.5%
Show Previous Ratings
Nov-11-26 05:00PM
Nov-04-26 02:34PM
(Earnings Whispers)
+4.68%
Nov-03-26 05:46PM
05:21PM
Oct-27-26 07:00AM
07:16PM
Loading…
Oct-26-26 07:16PM
Sep-22-26 07:00AM
Sep-14-26 07:00AM
Aug-31-26 06:30PM
Aug-24-26 07:00AM
Aug-07-26 05:00PM
Jul-29-26 05:00PM
Jul-28-26 05:22PM
05:01PM
05:00PM
05:01PM
Loading…
Jul-14-26 05:01PM
Jul-08-26 07:38AM
Jun-29-26 04:30PM
Jun-10-26 06:07PM
Jun-09-26 04:05PM
May-22-26 06:23PM
May-18-26 07:00AM
May-15-26 06:23PM
May-05-26 05:01PM
Apr-28-26 05:13PM
(Associated Press)
-13.77%
05:01PM
Apr-15-26 05:01PM
Mar-23-26 06:55AM
Mar-17-26 05:01PM
Mar-04-26 11:30AM
12:41PM
Loading…
Feb-20-26 12:41PM
Feb-10-26 11:01AM
Feb-09-26 07:00AM
Feb-03-26 06:07PM
04:00PM
07:05AM
Feb-02-26 06:30PM
06:15PM
05:13PM
(Associated Press Finance)
05:01PM
Jan-29-26 06:15PM
10:00AM
Jan-27-26 07:02AM
Jan-20-26 05:01PM
Jan-19-26 05:01PM
Jan-05-26 08:09AM
Dec-15-25 09:16AM
Dec-05-25 06:35PM
Dec-04-25 11:30AM
Dec-03-25 12:27PM
Dec-01-25 04:34PM
Nov-19-25 05:01PM
Nov-06-25 07:12AM
Nov-05-25 04:05PM
Nov-04-25 07:30PM
06:35PM
05:46PM
(Associated Press Finance)
05:01PM
07:49AM
Nov-03-25 07:34AM
Oct-30-25 05:01PM
Oct-28-25 10:00AM
Oct-23-25 07:00AM
Oct-14-25 05:01PM
Sep-30-25 05:01PM
Sep-12-25 08:19AM
06:10AM
Aug-28-25 11:30AM
Aug-12-25 05:30PM
08:56AM
Aug-08-25 05:01PM
Aug-05-25 08:18AM
Jul-31-25 03:25AM
Jul-29-25 07:00PM
06:15PM
05:11PM
(Associated Press Finance)
05:01PM
09:41AM
Jul-28-25 09:27AM
Jul-23-25 10:00AM
Jul-22-25 10:00AM
Jul-21-25 05:00PM
Jul-16-25 05:00PM
Jul-14-25 05:00PM
Jul-09-25 09:29AM
Jul-08-25 05:00PM
Jun-05-25 09:05AM
May-30-25 11:31AM
May-28-25 05:00PM
May-14-25 01:37PM
May-08-25 06:45AM
May-06-25 05:15PM
08:49AM
May-05-25 05:00PM
May-02-25 03:12AM
02:54AM
(Thomson Reuters StreetEvents)
May-01-25 07:48PM
Apr-30-25 07:30PM
06:50PM
05:47PM
(Associated Press Finance)
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
RICHARDSON SAMUEL VP, Controller and PAO Nov 16 '26 Option Exercise 75.57 235 17,759 1,414 Nov 18 04:30 PM LAMPKIN ROBIN E. SVP, GC & Secretary Nov 16 '26 Option Exercise 75.57 1,310 98,997 8,266 Nov 18 04:30 PM MINICUCCI JAMES P. SVP and GM, Personal Care Nov 16 '26 Option Exercise 75.57 1,259 95,143 9,432 Nov 18 04:30 PM WHITAKER WILLIAM SVP, CFO & PFO Nov 16 '26 Option Exercise 75.57 367 27,734 2,582 Nov 18 04:30 PM MUSA OSAMA M SVP and CTO Nov 16 '26 Option Exercise 75.57 2,147 162,249 40,469 Nov 18 04:30 PM NOVO GUILLERMO Chair of the Board and CEO Nov 16 '26 Option Exercise 75.57 9,366 707,789 153,801 Nov 18 04:30 PM Drury Eileen SVP and Chief HRO Nov 16 '26 Option Exercise 75.57 1,332 100,659 9,415 Nov 18 04:30 PM Assis Alessandra Faccin SVP and GM, Life Sciences Nov 13 '26 Option Exercise 76.47 1,376 105,223 9,632 Nov 17 04:30 PM WHITAKER WILLIAM SVP, CFO & PFO Nov 13 '26 Option Exercise 76.47 236 18,047 2,285 Nov 17 04:30 PM Drury Eileen SVP and Chief HRO Nov 13 '26 Option Exercise 76.47 888 67,905 8,495 Nov 17 04:30 PM RICHARDSON SAMUEL VP, Controller and PAO Nov 13 '26 Option Exercise 76.47 151 11,547 1,223 Nov 17 04:30 PM LAMPKIN ROBIN E. SVP, GC & Secretary Nov 13 '26 Option Exercise 76.47 890 68,058 7,215 Nov 17 04:30 PM MUSA OSAMA M SVP and CTO Nov 13 '26 Option Exercise 76.47 1,431 109,429 39,008 Nov 17 04:30 PM NOVO GUILLERMO Chair of the Board and CEO Nov 13 '26 Option Exercise 76.47 9,273 709,106 148,316 Nov 17 04:30 PM MINICUCCI JAMES P. SVP and GM, Personal Care Nov 13 '26 Option Exercise 76.47 1,048 80,141 8,501 Nov 17 04:30 PM Caceres Dago SVP & GM, Specialty Additives Nov 13 '26 Option Exercise 76.47 767 58,652 1,297 Nov 17 04:30 PM MUSA OSAMA M SVP and CTO Sep 21 '26 Option Exercise 69.06 10,418 719,467 41,224 Sep 23 04:30 PM LAMPKIN ROBIN E. SVP, GC & Secretary Aug 11 '26 Option Exercise 74.58 1,806 134,691 6,825 Aug 12 04:30 PM MUSA OSAMA M SVP and CTO Jul 29 '26 Option Exercise 57.96 1,267 73,435 30,806 Jul 30 04:30 PM Assis Alessandra Faccin SVP and GM, Life Sciences Jul 27 '26 Option Exercise 66.38 3,215 213,412 9,099 Jul 29 04:30 PM MINICUCCI JAMES P. SVP and GM, Personal Care May 08 '26 Option Exercise 55.01 4,310 237,093 8,567 May 11 04:30 PM Kulkarni Ashish K Director Jan 21 '26 Option Exercise 0.00 2,113 0 2,113 Jan 22 04:30 PM
Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.
Chairman & CEO Mr. Guillermo Novo
Senior VP Mr. William C. Whitaker C.F.A.
Senior VP & CTO Dr. Osama M. Musa Ph.D.
Senior VP & GM of Personal Care Mr. James P. Minicucci
Senior VP and GM of Life Sciences & Intermediates Ms. Alessandra Faccin Assis